| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SYRE | Spyre Therapeutics, Inc. | Turtle Cameron | Chief Executive Officer | Feb 15, 2024 | Option Exercise | $9.82 | 400 | 3,928 | 746,907 | Feb 20, 2024, 09:21 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Souza Marcio | Director | Aug 25, 2022 | Buy | $0.56 | 90,000 | 50,472 | 90,000 | Aug 25, 2022, 07:37 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Hanley Jr. Michael Conick | Chief Commercial Officer | Jun 08, 2022 | Buy | $0.71 | 28,200 | 20,022 | 36,200 | Jun 10, 2022, 06:24 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Mar 16, 2022 | Buy | $2.34 | 80,079 | 187,705 | 550,540 | Mar 18, 2022, 06:46 AM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Mar 11, 2022 | Buy | $2.06 | 34,777 | 71,780 | 363,572 | Mar 15, 2022, 06:32 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Mar 14, 2022 | Buy | $1.93 | 67,472 | 130,221 | 431,044 | Mar 15, 2022, 06:32 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Mar 15, 2022 | Buy | $1.86 | 42,417 | 78,942 | 473,461 | Mar 15, 2022, 06:32 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Alspaugh Jonathan | Chief Financial Officer | Mar 11, 2022 | Buy | $2.08 | 75,000 | 156,000 | 165,372 | Mar 15, 2022, 06:30 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Shanafelt Armen | Director | Dec 10, 2021 | Buy | $3.65 | 13,516 | 49,333 | 135,315 | Dec 13, 2021, 08:41 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Shanafelt Armen | Director | Dec 13, 2021 | Buy | $3.65 | 14,685 | 53,600 | 150,000 | Dec 13, 2021, 08:41 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Shanafelt Armen | Director | Dec 09, 2021 | Buy | $3.67 | 121,799 | 446,759 | 121,799 | Dec 13, 2021, 08:41 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Dec 09, 2021 | Buy | $3.70 | 43,108 | 159,500 | 318,269 | Dec 13, 2021, 08:39 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Dec 10, 2021 | Buy | $3.75 | 10,526 | 39,473 | 328,795 | Dec 13, 2021, 08:39 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Alspaugh Jonathan | Chief Financial Officer | Dec 09, 2021 | Buy | $3.72 | 50,000 | 186,000 | 90,372 | Dec 13, 2021, 08:37 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Alspaugh Jonathan | Chief Financial Officer | Aug 16, 2021 | Buy | $6.37 | 9,780 | 62,275 | 9,780 | Aug 18, 2021, 05:21 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Alspaugh Jonathan | Chief Financial Officer | Aug 17, 2021 | Buy | $6.50 | 23,392 | 151,985 | 33,172 | Aug 18, 2021, 05:21 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Alspaugh Jonathan | Chief Financial Officer | Aug 18, 2021 | Buy | $6.72 | 7,200 | 48,400 | 40,372 | Aug 18, 2021, 05:21 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Apr 30, 2020 | Buy | $4.75 | 165,000 | 783,750 | 538,469 | May 04, 2020, 07:30 AM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Oct 04, 2019 | Option Exercise | $6.28 | 18,265 | 114,689 | 371,908 | Oct 07, 2019, 04:09 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Jun 12, 2019 | Buy | $6.11 | 12,217 | 74,705 | 333,955 | Jun 14, 2019, 05:22 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Jun 13, 2019 | Buy | $6.17 | 14,406 | 88,836 | 348,361 | Jun 14, 2019, 05:22 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Jun 14, 2019 | Buy | $6.23 | 5,282 | 32,913 | 353,643 | Jun 14, 2019, 05:22 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | May 22, 2019 | Buy | $6.86 | 3,809 | 26,128 | 321,738 | May 22, 2019, 04:55 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | May 20, 2019 | Buy | $6.55 | 8,989 | 58,923 | 304,135 | May 22, 2019, 04:55 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | May 21, 2019 | Buy | $6.89 | 13,794 | 94,981 | 317,929 | May 22, 2019, 04:55 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | May 15, 2019 | Buy | $6.76 | 6,256 | 42,269 | 283,408 | May 17, 2019, 05:04 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | May 16, 2019 | Buy | $6.83 | 5,520 | 37,691 | 288,928 | May 17, 2019, 05:04 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | May 17, 2019 | Buy | $6.65 | 6,218 | 41,335 | 295,146 | May 17, 2019, 05:04 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Feb 15, 2019 | Buy | $7.10 | 719 | 5,103 | 277,152 | May 17, 2019, 05:04 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Feb 06, 2019 | Option Exercise | $6.18 | 8,756 | 54,126 | 276,433 | Feb 08, 2019, 04:15 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Feb 15, 2018 | Buy | $6.02 | 2,000 | 12,040 | 94,793 | Dec 10, 2018, 05:40 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Aug 15, 2018 | Buy | $9.13 | 994 | 9,075 | 95,787 | Dec 10, 2018, 05:40 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Dec 07, 2018 | Option Exercise | $4.37 | 171,890 | 751,816 | 267,677 | Dec 10, 2018, 05:40 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Schuchart Aaron | Chief Business Officer | Sep 27, 2018 | Sale | $9.50 | 6,000 | 57,005 | 8,400 | Sep 28, 2018, 05:11 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Schuchart Aaron | Chief Business Officer | Aug 17, 2018 | Option Exercise | $3.50 | 8,500 | 29,750 | 8,500 | Aug 21, 2018, 04:24 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | GEORGIOU GEORGE | Director | Aug 13, 2018 | Option Exercise | $5.91 | 37,333 | 220,784 | 175,861 | Aug 15, 2018, 04:40 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | Interim CEO | Jul 12, 2018 | Option Exercise | $6.76 | 38,866 | 262,764 | 92,793 | Jul 16, 2018, 09:04 AM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | Interim CEO | Jul 11, 2018 | Option Exercise | $5.46 | 3,307 | 18,056 | 53,927 | Jul 13, 2018, 09:05 AM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Novartis Bioventures Ltd | 10% Owner | May 11, 2018 | Sale | $10.06 | 19,550 | 196,673 | 2,175,314 | May 14, 2018, 04:01 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Novartis Bioventures Ltd | 10% Owner | May 09, 2018 | Sale | $10.11 | 51,230 | 517,935 | 2,217,589 | May 11, 2018, 04:28 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Novartis Bioventures Ltd | 10% Owner | May 10, 2018 | Sale | $10.13 | 22,725 | 230,204 | 2,194,864 | May 11, 2018, 04:28 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | NOVARTIS AG | 10% Owner | May 07, 2018 | Sale | $10.11 | 15,548 | 157,190 | 2,295,376 | May 09, 2018, 04:01 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Novartis Bioventures Ltd | 10% Owner | May 08, 2018 | Sale | $10.03 | 26,557 | 266,367 | 2,268,819 | May 09, 2018, 04:01 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | Interim CEO | Feb 15, 2018 | Option Exercise | $5.46 | 15,211 | 83,052 | 50,620 | Feb 20, 2018, 12:00 AM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | Interim CEO | Dec 06, 2017 | Buy | $4.92 | 4,888 | 24,072 | 32,009 | Dec 08, 2017, 07:06 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | Interim CEO | Dec 07, 2017 | Buy | $4.99 | 2,800 | 13,967 | 34,809 | Dec 08, 2017, 07:06 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | Interim CEO | Dec 08, 2017 | Buy | $5.07 | 600 | 3,039 | 35,409 | Dec 08, 2017, 07:06 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | York Charles N II | Chief Financial Officer and VP | Dec 01, 2017 | Buy | $4.59 | 6,500 | 29,855 | 21,287 | Dec 05, 2017, 09:07 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | York Charles N II | Chief Financial Officer and VP | Dec 04, 2017 | Buy | $4.97 | 3,259 | 16,197 | 24,546 | Dec 05, 2017, 09:07 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | York Charles N II | Chief Financial Officer and VP | Dec 05, 2017 | Buy | $4.76 | 10,241 | 48,700 | 34,787 | Dec 05, 2017, 09:07 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | York Charles N II | Chief Financial Officer and VP | Aug 15, 2016 | Buy | $3.99 | 2,000 | 7,974 | 10,828 | Dec 05, 2017, 09:07 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | York Charles N II | Chief Financial Officer and VP | Feb 15, 2017 | Buy | $4.28 | 2,000 | 8,568 | 12,828 | Dec 05, 2017, 09:07 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | York Charles N II | Chief Financial Officer and VP | Aug 15, 2017 | Buy | $2.52 | 1,959 | 4,929 | 14,787 | Dec 05, 2017, 09:07 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | Director | Dec 04, 2017 | Buy | $4.98 | 7,956 | 39,624 | 22,056 | Dec 05, 2017, 09:04 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | Director | Dec 05, 2017 | Buy | $4.93 | 5,065 | 24,976 | 27,121 | Dec 05, 2017, 09:04 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | Director | Dec 01, 2017 | Buy | $4.53 | 4,100 | 18,578 | 14,100 | Dec 05, 2017, 09:04 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | ISALY SAMUEL D | 10% Owner | Feb 16, 2017 | Buy | $5.04 | 30,500 | 153,720 | 1,390,724 | Feb 21, 2017, 05:58 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | OrbiMed Capital GP V LLC | 10% Owner | Feb 17, 2017 | Buy | $5.19 | 71,800 | 372,642 | 1,462,524 | Feb 21, 2017, 05:58 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | ISALY SAMUEL D | 10% Owner | Feb 21, 2017 | Buy | $5.36 | 7,000 | 37,520 | 1,469,524 | Feb 21, 2017, 05:58 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | LILLY ELI & CO | 10% Owner | Apr 12, 2016 | Buy | $10.00 | 500,000 | 5,000,000 | 2,568,543 | Apr 14, 2016, 06:41 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony | Director | Apr 12, 2016 | Buy | $10.00 | 10,000 | 100,000 | 10,000 | Apr 12, 2016, 05:10 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Novartis Bioventures Ltd | 10% Owner | Apr 12, 2016 | Buy | $10.00 | 300,000 | 3,000,000 | 2,310,924 | Apr 12, 2016, 05:09 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Cox Russell J. | Director | Apr 12, 2016 | Buy | $10.00 | 7,000 | 70,000 | 7,000 | Apr 12, 2016, 05:06 PM |
Menu